Announcements
- Assembly Biosciences to Present Data at Upcoming International Herpesvirus Workshop and EASL Congress™ 2024
- Assembly Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights
- Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights
- Assembly Biosciences Announces Effective Date of Reverse Stock Split
- Assembly Biosciences Provides Anticipated Development Milestones for 2024
- Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Assembly Biosciences Presents New Data Highlighting Viral Hepatitis Portfolio at AASLD The Liver Meeting®
- Assembly Biosciences Reports Third Quarter 2023 Financial Results and Recent Updates
- Assembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief Medical Officer
- Assembly Biosciences to Present New Data at AASLD The Liver Meeting®
More ▼
Key statistics
On Friday, Assembly Biosciences Inc (V7B:DUS) closed at 13.70, -7.33% below its 52-week high of 14.78, set on Oct 17, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 13.50 |
---|---|
High | 13.70 |
Low | 13.50 |
Bid | 13.35 |
Offer | 14.15 |
Previous close | 13.65 |
Average volume | 345.00 |
---|---|
Shares outstanding | 5.51m |
Free float | 3.69m |
P/E (TTM) | -- |
Market cap | 83.53m USD |
EPS (TTM) | -11.22 USD |
Data delayed at least 15 minutes, as of May 31 2024 18:30 BST.
More ▼